Investor Relations | Financial Information

Capex, Depeciation, R&D

Unit:Yen millions / Fiscal Year 2016/3 2017/3 2018/3 2019/3 2020/3
Investment in facilities
Share of cash flow (%)
160,674
108.5
167,631
72.1
178,612
114.8
173,592
91.9
173,429
94.9
Depreciation expenses
Share of net sales (%)
83,224
7.2
87,491
7.4
92,171
7.2
106,631
7.7
124,984
9.2
Cash flow
(Net income + Depreciation expenses)
148,052 232,590 155,634 188,836 182,764
Research and development expenses
 Share of net sales (%)
84,920
7.4
91,254
7.7
102,641
8.1
115,155
8.3
117,489
8.6
Interactive Analysis Tool

Recommendations

PAGE TOP